Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors

被引：0
|
作者：
Zi-yi Liu
Xue-feng Kan
Li-jie Zhang
Joyman Makamure
Qing Li
Dan Zhao
Guo-feng Zhou
Gan-sheng Feng
Chuan-sheng Zheng
Bin Liang
机构：
[1] Huazhong University of Science and Technology,Department of Radiology, Union Hospital, Tongji Medical College
[2] Hubei Province Key Laboratory of Molecular Imaging,undefined
来源：
Current Medical Science | 2022年 / 42卷
关键词：
chemoembolization; therapeutic; apatinib; molecular targeted therapy; survival; factor analysis; statistical;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1021
页数：6
相关论文
共 50 条
  • [31] The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma
    Lee, Shou Wu
    Lee, Teng Yu
    Peng, Yen Chun
    Yang, Sheng Shun
    Yeh, Hong Zen
    Chang, Chi Sen
    JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (05) : 287 - 292
  • [32] Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas
    Ni, Jia-yan
    Kong, Jian
    Sun, Hong-liang
    Chen, Yao-ting
    Luo, Jiang-hong
    Wang, Wei-dong
    Chen, Dong
    Jiang, Xiong-ying
    Xu, Lin-feng
    ACADEMIC RADIOLOGY, 2018, 25 (04) : 423 - 429
  • [33] Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
    Gu, Huiying
    Li, Jing
    You, Nan
    Wu, Ke
    Wang, Zheng
    Wang, Liang
    Zhu, Yinan
    Liu, Qinqin
    Peng, Xuehui
    Zheng, Lu
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [34] Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma
    中华医学杂志(英文版), 2009, (17) : 1990 - 1995
  • [35] TRANSARTERIAL CHEMOEMBOLIZATION IN THE INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA: SURVIVAL ANALYSIS
    Tajibaev, T. K.
    Medeubekov, U. Sh
    Chormanov, A. T.
    Sagatov, I. Y.
    Kaniev, Sh A.
    Issamatov, B. K.
    Baimakhanov, B. B.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 111 - 114
  • [36] Prognostic factors of transarterial chemoembolization/transarterial embolization for hepatocellular carcinoma patients with prolonged survival of more than 3 years
    Sarvesh, G.
    Jeng, C. M.
    Tsai, W. M.
    Huang, Y. W.
    Hu, J. T.
    Yang, S. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 337 - 337
  • [37] Hepatocellular Carcinoma: Combined Transarterial Chemoembolization and Ablation
    Herren, Josi L.
    Disomma, Nerina
    Ray, Charles E., Jr.
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2019, 36 (03) : 279 - 283
  • [38] Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
    Hanif, Farina M.
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Abbas, Zaigham
    Hassan, Syed Mujahid
    Mubarak, Muhammed
    MIDDLE EAST JOURNAL OF CANCER, 2014, 5 (04) : 197 - 205
  • [39] Platelet-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization plus apatinib in the treatment of advanced hepatocellular carcinoma
    Chen, Lei
    Ke, Zunqian
    Xiong, Fu
    Kan, Xuefeng
    Ren, Yanqiao
    Cao, Yanyan
    Sun, Tao
    Yan, Liangliang
    Zhou, Guofeng
    Zheng, Chuansheng
    ANTI-CANCER DRUGS, 2020, 31 (09) : 966 - 972
  • [40] Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma: Prognostic Value of Albumin
    Sanjeevi, S.
    Duncan, C.
    McElroy, K.
    Bhadkamkar, N. A.
    Zvavanjanja, R. C.
    Wray, C.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S110 - S110
12345